K2M Completes Follow-On Offering of Common Stock
02.12.15
This is only gets display when printing
The Firm represented K2M Group Holdings, Inc. (“K2M”) in connection with a public offering of 6,951,738 shares of common stock by K2M and certain selling stockholders at a public offering price of $18.75 per share.
K2M sold 2,044,990 shares of common stock in the offering. The selling stockholders sold 4,906,748 shares of common stock in the offering, including 906,748 shares that were offered and sold pursuant to the full exercise of the underwriters’ option to purchase additional shares. Shares of K2M are listed on NASDAQ Global Select Market under the ticker symbol “KTWO.”
Piper Jaffray & Co., Barclays Capital Inc. and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. William Blair & Company, L.L.C. and Cowen and Company, LLC acted as co-managers.
K2M is a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques.
The Simpson Thacher team included Kenneth Wallach, Jonathan Ozner, Kai Fan, Wabi Jain and Sara Campbell (Capital Markets); James Rapp and Janice Brunner (Public Company Advisory Practice); Marcy Geller and Joseph Tootle (Tax); Lindsay Thomas and Josh Bergman (Credit); David Rubinsky and Patricia Adams (Executive Compensation and Employee Benefits); and Samantha Himelman (Intellectual Property).